C 17
Pill imprint C 17 has been identified as Cefprozil 500 mg.
Cefprozil is used in the treatment of sinusitis; bladder infection; upper respiratory tract infection; kidney infections; tonsillitis/pharyngitis (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy.
Cefprozil 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Cefprozil Images
- Imprint:
-
C 17
- Strength:
- 500 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
sodium starch glycolate type A potato
magnesium stearate
hypromellose 2910 (5 mPa.s)
polyethylene glycol 400
polysorbate 80
titanium dioxide
shellac
ferrosoferric oxide
propylene glycol
ammonia
- Drug Class:
- Second generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Aurobindo Pharma
- National Drug Code (NDC):
- 65862-0069
| NDC Code | Manufacturer / Repackager |
|---|---|
| 59762-2221 | Greenstone LLC |
Note: Inactive ingredients may vary.
Advertisement
More Cefprozil resources
- Cefprozil (Wolters Kluwer)
- Cefprozil Suspension (Wolters Kluwer)
- cefprozil (Cerner Multum)
- cefprozil (Micromedex) - Includes Dosage Information
- Cefprozil (AHFS DI)
- Cefprozil (FDA)
- Cefprozil Tablets (FDA)
- Cefprozil (Wolters Kluwer)
Search Again
